These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1182 related items for PubMed ID: 7621683

  • 1. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 2. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 3. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 4. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
    Datey S, Gaur LN, Saxena BN.
    Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 6. Ask the experts: progestin-only contraceptives.
    Hatcher RA, Schnare S.
    Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
    [Abstract] [Full Text] [Related]

  • 7. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Oyelola OO.
    Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
    [Abstract] [Full Text] [Related]

  • 8. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
    Anwar M, Soejono SK, Maruo T, Abdullah N.
    Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
    [Abstract] [Full Text] [Related]

  • 9. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T, Olsson SE, Gudmundson J.
    Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
    [Abstract] [Full Text] [Related]

  • 10. Hormonal implants: contraception for a new century.
    Darney PD.
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [Abstract] [Full Text] [Related]

  • 11. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK, Affandi B, Korver T.
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [Abstract] [Full Text] [Related]

  • 12. Injectable and implantable contraceptives.
    Cullins VE.
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
    [Abstract] [Full Text] [Related]

  • 13. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS.
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [Abstract] [Full Text] [Related]

  • 14. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Apr; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 15. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I, Khan AR, Jahan FA.
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [Abstract] [Full Text] [Related]

  • 16. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
    American Health Consultants.
    Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
    [Abstract] [Full Text] [Related]

  • 17. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 18. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
    Alvarez-Sanchez F, Brache V, Jackanicz T, Faundes A.
    Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
    [Abstract] [Full Text] [Related]

  • 20. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS.
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.